192 related items for PubMed ID: 16855166
1. Anti-TNF and sex hormones.
Cutolo M, Sulli A, Capellino S, Villaggio B, Montagna P, Pizzorni C, Paolino S, Seriolo B, Felli L, Straub RH.
Ann N Y Acad Sci; 2006 Jun; 1069():391-400. PubMed ID: 16855166
[Abstract] [Full Text] [Related]
2. Sex hormone concentrations in patients with rheumatoid arthritis are not normalized during 12 weeks of anti-tumor necrosis factor therapy.
Straub RH, Härle P, Atzeni F, Weidler C, Cutolo M, Sarzi-Puttini P.
J Rheumatol; 2005 Jul; 32(7):1253-8. PubMed ID: 15996060
[Abstract] [Full Text] [Related]
3. Increased estrogen formation and estrogen to androgen ratio in the synovial fluid of patients with rheumatoid arthritis.
Castagnetta LA, Carruba G, Granata OM, Stefano R, Miele M, Schmidt M, Cutolo M, Straub RH.
J Rheumatol; 2003 Dec; 30(12):2597-605. PubMed ID: 14719200
[Abstract] [Full Text] [Related]
4. Tumor necrosis factor inhibits conversion of dehydroepiandrosterone sulfate (DHEAS) to DHEA in rheumatoid arthritis synovial cells: a prerequisite for local androgen deficiency.
Weidler C, Struharova S, Schmidt M, Ugele B, Schölmerich J, Straub RH.
Arthritis Rheum; 2005 Jun; 52(6):1721-9. PubMed ID: 15934093
[Abstract] [Full Text] [Related]
5. Synovial fluid estrogens in rheumatoid arthritis.
Cutolo M, Villaggio B, Seriolo B, Montagna P, Capellino S, Straub RH, Sulli A.
Autoimmun Rev; 2004 Mar; 3(3):193-8. PubMed ID: 15110231
[Abstract] [Full Text] [Related]
6. Estrone/17beta-estradiol conversion to, and tumor necrosis factor inhibition by, estrogen metabolites in synovial cells of patients with rheumatoid arthritis and patients with osteoarthritis.
Schmidt M, Hartung R, Capellino S, Cutolo M, Pfeifer-Leeg A, Straub RH.
Arthritis Rheum; 2009 Oct; 60(10):2913-22. PubMed ID: 19790073
[Abstract] [Full Text] [Related]
7. Estrogens and autoimmune diseases.
Cutolo M, Capellino S, Sulli A, Serioli B, Secchi ME, Villaggio B, Straub RH.
Ann N Y Acad Sci; 2006 Nov; 1089():538-47. PubMed ID: 17261796
[Abstract] [Full Text] [Related]
8. Anti-interleukin-6 receptor antibody therapy favors adrenal androgen secretion in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled study.
Straub RH, Härle P, Yamana S, Matsuda T, Takasugi K, Kishimoto T, Nishimoto N.
Arthritis Rheum; 2006 Jun; 54(6):1778-85. PubMed ID: 16729287
[Abstract] [Full Text] [Related]
9. Long-term anti-tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion.
Straub RH, Pongratz G, Schölmerich J, Kees F, Schaible TF, Antoni C, Kalden JR, Lorenz HM.
Arthritis Rheum; 2003 Jun; 48(6):1504-12. PubMed ID: 12794817
[Abstract] [Full Text] [Related]
10. Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis.
Straub RH, Paimela L, Peltomaa R, Schölmerich J, Leirisalo-Repo M.
Arthritis Rheum; 2002 Mar; 46(3):654-62. PubMed ID: 11920401
[Abstract] [Full Text] [Related]
11. Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes--androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5alpha-reduced androgens.
Schmidt M, Weidler C, Naumann H, Anders S, Schölmerich J, Straub RH.
Arthritis Res Ther; 2005 Mar; 7(5):R938-48. PubMed ID: 16207335
[Abstract] [Full Text] [Related]
12. Aromatase and regulation of the estrogen-to-androgen ratio in synovial tissue inflammation: common pathway in both sexes.
Capellino S, Straub RH, Cutolo M.
Ann N Y Acad Sci; 2014 May; 1317():24-31. PubMed ID: 24684533
[Abstract] [Full Text] [Related]
13. Increased DHEAS levels in patients with rheumatoid arthritis after treatment with tumor necrosis factor antagonists: evidence for improved adrenal function.
Ernestam S, Hafström I, Werner S, Carlström K, Tengstrand B.
J Rheumatol; 2007 Jul; 34(7):1451-8. PubMed ID: 17477470
[Abstract] [Full Text] [Related]
14. Interleukin-21 induces T-cell activation and proinflammatory cytokine secretion in rheumatoid arthritis.
Li J, Shen W, Kong K, Liu Z.
Scand J Immunol; 2006 Nov; 64(5):515-22. PubMed ID: 17032244
[Abstract] [Full Text] [Related]
15. Inflammation and sex hormone metabolism.
Schmidt M, Naumann H, Weidler C, Schellenberg M, Anders S, Straub RH.
Ann N Y Acad Sci; 2006 Jun; 1069():236-46. PubMed ID: 16855150
[Abstract] [Full Text] [Related]
16. Gonadal and adrenal steroid hormones in plasma and synovial fluid of patients with rheumatoid arthritis.
Rovensky J, Radikova Z, Imrich R, Greguska O, Vigas M, Macho L.
Endocr Regul; 2004 Dec; 38(4):143-9. PubMed ID: 15841793
[Abstract] [Full Text] [Related]
17. The TNF superfamily member LIGHT contributes to survival and activation of synovial fibroblasts in rheumatoid arthritis.
Pierer M, Brentano F, Rethage J, Wagner U, Hantzschel H, Gay RE, Gay S, Kyburz D.
Rheumatology (Oxford); 2007 Jul; 46(7):1063-70. PubMed ID: 17426140
[Abstract] [Full Text] [Related]
18. Tumor necrosis factor-alpha induces vascular endothelial growth factor-C expression in rheumatoid synoviocytes.
Cha HS, Bae EK, Koh JH, Chai JY, Jeon CH, Ahn KS, Kim J, Koh EM.
J Rheumatol; 2007 Jan; 34(1):16-9. PubMed ID: 17216674
[Abstract] [Full Text] [Related]
19. Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis.
Seriolo B, Paolino S, Sulli A, Ferretti V, Cutolo M.
Ann N Y Acad Sci; 2006 Jun; 1069():420-7. PubMed ID: 16855169
[Abstract] [Full Text] [Related]
20. Cytokinin panel in rheumatoid arthritis and correlation with histological patterns of synovitis -- active type of disease.
Avrămescu C, Vere CC, Mărgăritescu C, Turculeanu A, Bălăşoiu M, Rogoz S.
Rom J Morphol Embryol; 2005 Jun; 46(2):87-92. PubMed ID: 16286991
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
